To Top

Press releases

1392 Articles available
Appointment

Perrigo Appoints James Dillard To Role Of Chief Scientific Officer

PR-M01-19-NI-044
Hematology

Newly Discovered Phagocyte Plays Role in Autoimmune Disease

PR-M01-19-NI-044
Investment

CVS Health Announces $100 Million Community Commitment Following Acquisition Of Aetna

PR-M01-19-NI-044
Oncology Drugs

China Cancer Drugs Market 2018-2024: Rising Demand of Targeted Drug Therapy and the Patent Expiration of Key Cancer Drugs

PR-M01-19-NI-044
Lyophilization

Flow Sciences, Inc. Partners with Three Companies to Contain Lyophilization Process of New HPAPI

PR-M01-19-NI-052
Robotics

The Global Wearable Robotic Exoskeleton Market is Projected to Reach $5.4 Billion by 2028

PR-M01-19-NI-043
Expression System

Fujifilm Announces the Launch of Its Next Generation Apollo™ X Advanced Mammalian Expression System

PR-M01-19-NI-042
Myopia

SightGlass Vision Multicenter Trial to Study Novel Eyeglasses to Control Nearsightedness for FDA Approval

PR-M01-19-NI-040
Precision Diagnostics

Pillar Biosciences Enters Strategic Partnership with China Biotech Services Holdings to Deliver Precision Diagnostics to Markets in Asia

PR-M01-19-NI-041
Partnership

Abbott and "Malaria No More" Work Together to End Malaria in Odisha, India

PR-M01-19-NI-039
Investment

New Opioid-alternative Raises $3.25 Million for Phase I Trials

PR-M01-19-NI-037
Announcement

A Path Forward for Increasing Kidney Transplantation

PR-M01-19-NI-036
ALS Research

Collaborative Medicinal Development, LLC Reports that Lead Drug Modifies ALS Progression

PR-M01-19-NI-035
Hematology/Oncology

Blood Cancer Therapeutics: Global Markets to 2023

PR-M01-19-NI-034
Medical Device

Amgen Makes All Repatha® (evolocumab) Device Options Available In The US At A 60 Percent Reduced List Price

PR-M01-19-NI-033
RNA Splicing

Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets

PR-M01-19-NI-032
Immuno-oncology

Regeneron and Sanofi Restructure Immuno-Oncology Collaboration for Discovery and Development Programs

PR-M01-19-NI-031
Leadership

AstraZeneca Announces Organizational Changes

PR-M01-19-NI-029
Approval

Novel Intrasaccular Aneurysm Treatment Device Receives FDA PMA Approval

PR-M01-19-NI-028
Facility

DPS Group Selected to Design Two cGMP Commercial Manufacturing Facilities for Brammer Bio

PR-M01-19-NI-036
Realignment

Theravance Biopharma Announces Alignment of Workforce with Focus on Key Strategic Priorities

PR-M01-19-NI-024
Immuno-Oncology

PrimeVax Immuno-Oncology Receives IND Permission From FDA

PR-M01-19-NI-026
Acquisition

Neogen Acquires Canadian Animal Genomics Laboratory

PR-M01-19-NI-011
Financial Results

Johnson & Johnson Announces Quarterly Dividend for First Quarter 2019

PR-M01-19-NI-010
J.P. Morgan Healthcare Conference

Grace Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference

PR-M01-19-NI-009
Immuno-oncology

GE Healthcare, Vanderbilt University Medical Center Partner for Safer, More Precise Immunotherapy Cancer Treatment

PR-M01-19-NI-023
FDA

PolarityTE Registers OsteoTE™ with U.S. Food and Drug Administration

PR-M01-19-NI-016
Drug Development

InventisBio and Betta Pharma to Co-Develop Novel Drug for Non-Small Cell Lung Cancer

PR-M01-19-NI-013
Acquisition

Rentschler Biopharma Completes Acquisition of U.S. Manufacturing Site

PR-M01-19-NI-021
Announcement

Baltimore Biotech Earns International Recognition for Advanced Development and Manufacturing Facility

PR-M01-19-NI-020
Appointment

Brammer Bolsters Leadership Team and Announces Chief Quality Officer

PR-M01-19-NI-019
M&A

Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company

PR-M01-19-NI-017
Announcement

Heron Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference

PR-M01-19-NI-006
Investment

China SXT Pharmaceuticals, Inc. Announces First Closing of Initial Public Offering

PR-M01-19-NI-007
Investment

Connect Biopharmaceuticals Completes $55 Million Series B Financing to Accelerate Clinical Development of Novel Immune Modulators

PR-M01-19-NI-005
Leadership

AbbVie Announces Executive Leadership Changes

PR-M01-19-NI-003
Biosimilar

Amgen Submits Biologics License Application for ABP 710 (Biosimilar Infliximab) To US Food And Drug Administration

PR-M01-19-NI-002
Launch

Launch of Generic Lialda® Delayed-Release Tablets Expands Mylan's Gastroenterology Product Offering

PR-M01-19-NI-001
Oncology

Rakuten Aspyrian Enrolling Phase 3 Trial of ASP-1929 for Head and Neck Cancer

PR-M12-18-NI-086
Market Prediction

Pneumatic Nebulizers Market Will Surge at 5.3% CAGR to Hit $875 Mn by 2024: Global Market Insights, Inc.

PR-M12-18-NI-083
Financing

Entrada Therapeutics Raises $59 Million Series A to Advance Intracellular Biologics Platform

PR-M12-18-NI-081
New Facility

Pall Opens Center of Excellence in Shanghai

PR-M12-18-NI-080
Advisory Board

Kymera Therapeutics Announces Expansion of Scientific Advisory Board to Advance Pre-Clinical Molecules Toward the Clinic

PR-M12-18-NI-079
Acquisition

Bruker Completes the Acquisition of Alicona Imaging GmbH

PR-M12-18-NI-082
Drug Development

Aristea Therapeutics Launches with Phase 2 Drug Candidate and $15M in Series A Funding from Novo Holdings A/S

PR-M12-18-NI-076
Inflammation

IFM Therapeutics Announces Newly Discovered Mechanism of Inflammatory Processes in the Body

PR-M12-18-NI-072
Appointment

AOBiome Therapeutics Announces Appointment of Dr. Judith Ng Cashin as Chief Medical Officer

PR-M12-18-NI-074
Biomanufacturing Facility

LakePharma Announces its cGMP MicroBiomanufacturing Center is Now Operational

PR-M12-18-NI-073
Alzheimer's Disease

Public Supports NIH Grants for Alzheimer's Microbes, Reports Alzheimer's Germ Quest, Inc.

PR-M12-18-NI-071
Strategic Alliance

Ajinomoto and XL-protein Forge Strategic Alliance to Develop PASylated Therapeutics Applying the Corynex® Platform

PR-M12-18-NI-069
Biologics Manufacturing

AGC Triples U.S. Biopharmaceutical Production Capacity

PR-M12-18-NI-066
Market Prediction

Emerging Medical Device Market Expected to Exceed $400 Billion by 2023

PR-M12-18-NI-065
Patient Adherence

Sempre Health and UPMC Health Plan Expand Program that Improves Affordability and Adherence for Critical Medications

PR-M12-18-NI-064
Collaboration

Marken and TrakCel Collaborate to Serve Cell and Gene Trials

PR-M12-18-NI-087
Medical Device

Statement from Jeff Shuren, Director of the CDRH, on Updated Safety Communication About Rates of Duodenoscope Contamination from Preliminary Postmarket Data

PR-M12-18-NI-062
Surgical Robots

The global Surgical Robots Market is Projected to Reach 6.5 billion by 2023 from USD 3.9 billion in 2018 at a CAGR of 10.4%

PR-M12-18-NI-061
Public Offering

Biohaven Announces Proposed Public Offering of Common Shares

PR-M12-18-NI-060
Clinical Trial Patient Populations

Amgen And Lazarex Cancer Foundation Team Up To Allow More Diversity In Clinical Trials

PR-M12-18-NI-059
Cell Expansion

Cell Expansion Market to Reach US $26 Billion by 2024, Says TMR

PR-M12-18-NI-058
Investment

GenEdit Closes $8.5 million Series Seed Financing

PR-M12-18-NI-056
Approval

World-first Approval For Multiple Myeloma Drug APLIDIN(R)

PR-M12-18-NI-055
Drug Development

Alligator Bioscience Starts Clinical Phase I Study With ATOR-1015

PR-M12-18-NI-054
Acquisition

Therapix Biosciences Provides Update Regarding FSD Acquisition

PR-M12-18-NI-052
Presentation

Abbott to Present at J.P. Morgan Healthcare Conference

PR-M12-18-NI-051
Appointment

BiomX Appoints Sailaja Puttagunta as Chief Medical Officer

PR-M12-18-NI-048
FDA

XOSPATA® (gilteritinib) Available at Biologics by McKesson

PR-M12-18-NI-045
Pricing

Tenax Therapeutics Announces Pricing of $10 Million Underwritten Offering

Expansion

NYCEDC Grants $1M To Quentis Therapeutics For Expansion of LifeSci Space in West Harlem

PR-M12-18-NI-043
Financing

Impel NeuroPharma Closes $67.5 Million Series D Financing

PR-M12-18-NI-040
Immuno-Oncology

Immuno-oncology Development Trends and Opportunities

PR-M12-18-NI-038
Alzheimer's Disease

First Drug Candidate From Eisai-UCL Research Collaboration To Enter Alzheimer's Disease Clinical Trials

PR-M12-18-NI-037
Financial Results

Amgen Announces 10 Percent Increase In 2019 First Quarter Dividend

PR-M12-18-NI-036
Expansion

Investor Group Purchases 110-Acre Pharmaceutical Campus in Huntsville, Alabama

PR-M12-18-NI-047
M&A

Histo-Scientific Research Laboratories and Vet Path Services Merge

PR-M12-18-NI-046
Gene and Cell Therapy

PPD Expands GMP Lab Testing Capabilities for Biologics

PR-M12-18-NI-035
Stem Cells

USRM announces U.S. Stem Cell Clinic Expansion of Products and Services

PR-M12-18-NI-033
FDA Acceptance

FDA Accepts Filing of New Estrogen-free Oral Contraceptive Developed by Exeltis

PR-M12-18-NI-030
FDA Approval

Olympus Spiration® Valve System Is FDA Approved for the Endobronchial Treatment of Emphysema

PR-M12-18-NI-029
Clinical Trial

Prometic to Initiate PBI-4050 Pivotal Phase 3 Clinical Trial in Alström Syndrome

PR-M12-18-NI-028
Appointment

Sartorius Supervisory Board Appoints Two New Executive Board Members

PR-M12-18-NI-027
License Agreement

Ablexis Announces Licensing Agreement with Allogene Therapeutics

PR-M12-18-NI-026
Leukemia

Astellas Presents Updated Results from Phase 1 Study of Gilteritinib Plus Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)

PR-M12-18-NI-025
Obesity

The Anti-Obesity Drugs Market Will Register a CAGR of Almost 8% by 2023

PR-M12-18-NI-024
Chronic Migraine

Migraine Drugs Market Size Worth $7.8 Billion by 2025 | CAGR: 18.0%: Grand View Research, Inc.

PR-M12-18-NI-023
Clinical Trials

Late-Breaking Clinical Trials Advance Targeted Therapies for Patients with CLL and Multiple Myeloma

PR-M12-18-NI-018
Phase 3

New DARZALEX® (daratumumab) Phase 3 Study Shows Efficacy and Safety Data of Anti-CD38 Monoclonal Antibody in Patients with Newly Diagnosed Multiple Myeloma

PR-M12-18-NI-019
Oncology

IMBRUVICA® (ibrutinib) Combination Regimen Significantly Improved Survival Versus the Chemoimmunotherapy FCR

PR-M12-18-NI-017
Alzheimer's Disease

Ocular Technology Provides Early Detection of Alzheimer's Disease

PR-M12-18-NI-014
Immunotherapy

Global Cancer Immunotherapy Market 2017-2027 Featuring Leading Players - Pfizer, Merck, Amgen and Roche

PR-M12-18-NI-012
Cystic Fibrosis

Aridis Expands Research Agreement with the Cystic Fibrosis Foundation and is Awarded FDA Expedited Program Designations

PR-M12-18-NI-013
ADC

Ajinomoto Bio-Pharma Services Introduces AJICAP Bioconjugation Technology for ADC Manufacturing

PR-M12-18-NI-010
Market Prediction

The Global Single-Use Bioprocessing Mmarket is Anticipated to Reach Revenues of Approximately $7 Billion by 2024

PR-M12-18-NI-009
Stem Cells

Platelets Grown from Stem Cells May be Alternative to Donated Platelets

PR-M12-18-NI-006
FDA Approval

FDA Approves First Biosimilar for Treatment of Adult Patients with Non-Hodgkin's Lymphoma

PR-M12-18-NI-004
Partnership

WuXi Biologics and ABL Bio Enter an Exclusive Development and Clinical Manufacturing Partnership for Multiple Bispecific Antibodies

PR-M12-18-NI-003
Research

Researchers Regrow Hair on Wounded Skin

PR-M12-18-NI-002
Clinical Trial

First Trial Launches to Test Effectiveness of Male Contraceptive Gel

PR-M12-18-NI-001
Market Prediction

The Global Cell Therapy Market Size is Expected to Reach USD 7.92 Billion by 2025

PR-M11-18-NI-106